• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[两种草药混合物]体外和体内的抗骨质疏松作用

Anti-Osteoporotic Effects of the Herbal Mixture of and In Vitro and In Vivo.

作者信息

Park Eunkuk, Lee Chang Gun, Kim Jeonghyun, Lim Eunguk, Hwang Seokjin, Yun Seung Hee, Yong Yoonjoong, Jeong Hyesoo, Kim Ji Ae, Jin Hyun-Seok, Jeong Seon-Yong

机构信息

Department of Medical Genetics, Ajou University School of Medicine, Suwon 16499, Korea.

Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon 16499, Korea.

出版信息

Plants (Basel). 2020 Aug 28;9(9):1114. doi: 10.3390/plants9091114.

DOI:10.3390/plants9091114
PMID:32872183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7570351/
Abstract

Osteoporosis is a porous bone disease caused by bone density loss, which increases the risk of fractures. (CO) and (AJ) have been used as traditional herbal medicine for various disorders in East Asia. Although the anti-osteoporotic effects of single extract of CO and AJ have already been reported, the synergistic effect of a combined mixture has not been studied. In this study, we investigated the effects of a CO and AJ herbal mixture on osteoporosis in in vitro and in vivo models. The results demonstrate that treatment with the CO and AJ mixture significantly promoted osteoblast differentiation of MC3T3-E1 mouse preosteoblasts through the upregulation of osteoblastic differentiation-associated genes such as alkaline phosphatase (), runt-related transcription factor 2 (), and bone gamma-carboxyglutamic acid-containing protein () while the mixture significantly inhibited differentiation of osteoclasts isolated from primary-cultured mouse monocytes. In addition, oral administration of CO and AJ mixture significantly prevented bone mineral density loss and trabecular bone structures in an ovariectomy-induced osteoporotic mouse model. These results suggest that the combination treatment of CO and AJ mixture might be a beneficial therapy for osteoporosis.

摘要

骨质疏松症是一种因骨密度降低引起的骨多孔性疾病,会增加骨折风险。在东亚地区,(此处原文中“(CO) and (AJ)”表述不完整,推测可能是两种草药名称的缩写,假设为“黄连(CO)和艾叶(AJ)”)黄连(CO)和艾叶(AJ)已被用作治疗各种疾病的传统草药。尽管已有报道称黄连(CO)和艾叶(AJ)的单一提取物具有抗骨质疏松作用,但它们混合后的协同作用尚未得到研究。在本研究中,我们在体外和体内模型中研究了黄连(CO)和艾叶(AJ)草药混合物对骨质疏松症的影响。结果表明,黄连(CO)和艾叶(AJ)混合物处理通过上调成骨细胞分化相关基因,如碱性磷酸酶()、 runt相关转录因子2()和骨γ-羧基谷氨酸蛋白(),显著促进了MC3T3-E1小鼠前成骨细胞的成骨细胞分化,同时该混合物显著抑制了从原代培养的小鼠单核细胞中分离出的破骨细胞的分化。此外,在去卵巢诱导的骨质疏松小鼠模型中,口服黄连(CO)和艾叶(AJ)混合物可显著预防骨矿物质密度损失和小梁骨结构破坏。这些结果表明,黄连(CO)和艾叶(AJ)混合物联合治疗可能是一种治疗骨质疏松症的有益疗法。

相似文献

1
Anti-Osteoporotic Effects of the Herbal Mixture of and In Vitro and In Vivo.[两种草药混合物]体外和体内的抗骨质疏松作用
Plants (Basel). 2020 Aug 28;9(9):1114. doi: 10.3390/plants9091114.
2
Anti-Osteoporotic Effects of Combined Extract of and in Osteoblast and Osteoclast Cells and Ovariectomized Mice.与联合提取物对成骨细胞和破骨细胞及去卵巢小鼠的抗骨质疏松作用。
Nutrients. 2019 Nov 9;11(11):2716. doi: 10.3390/nu11112716.
3
Inhibitory Effect of and Extracts on Osteoporotic Bone Loss In Vitro and In Vivo.、提取物对骨质疏松性骨丢失的体外和体内抑制作用。
Medicina (Kaunas). 2022 Mar 23;58(4):466. doi: 10.3390/medicina58040466.
4
Anti-Menopausal Effects of and Extract In Vitro and In Vivo.和提取物的体外和体内抗更年期作用。
Nutrients. 2020 Jan 30;12(2):369. doi: 10.3390/nu12020369.
5
Anti-Osteoporotic Effects of Kukoamine B Isolated from Cortex Extract on Osteoblast and Osteoclast Cells and Ovariectomized Osteoporosis Model Mice.从桑白皮提取物中分离得到的桑根酮 B 对成骨细胞和破骨细胞及去卵巢骨质疏松症模型小鼠的抗骨质疏松作用。
Int J Mol Sci. 2019 Jun 6;20(11):2784. doi: 10.3390/ijms20112784.
6
Osteoprotective Effects of Loganic Acid on Osteoblastic and Osteoclastic Cells and Osteoporosis-Induced Mice.龙牙草酸对成骨细胞和破骨细胞及骨质疏松症诱导小鼠的护骨作用。
Int J Mol Sci. 2020 Dec 28;22(1):233. doi: 10.3390/ijms22010233.
7
Anti-osteoporotic activity of harpagide by regulation of bone formation in osteoblast cell culture and ovariectomy-induced bone loss mouse models.通过调节成骨细胞培养中的骨形成以及卵巢切除诱导的骨质流失小鼠模型,哈帕苷的抗骨质疏松活性。
J Ethnopharmacol. 2016 Feb 17;179:66-75. doi: 10.1016/j.jep.2015.12.025. Epub 2015 Dec 19.
8
Scopolin Attenuates Osteoporotic Bone Loss in Ovariectomized Mice.莨菪亭可减轻去卵巢小鼠的骨质疏松性骨丢失。
Nutrients. 2020 Nov 20;12(11):3565. doi: 10.3390/nu12113565.
9
The effect of Lycii Radicis Cortex extract on bone formation in vitro and in vivo.地骨皮提取物对体外和体内骨形成的影响。
Molecules. 2014 Nov 26;19(12):19594-609. doi: 10.3390/molecules191219594.
10
The anti-osteoporotic effect of Yijung-tang in an ovariectomized rat model mediated by inhibition of osteoclast differentiation.益宫汤通过抑制破骨细胞分化对去卵巢大鼠模型的抗骨质疏松作用。
J Ethnopharmacol. 2013 Mar 7;146(1):83-9. doi: 10.1016/j.jep.2012.11.037. Epub 2012 Dec 5.

引用本文的文献

1
Protects Against Steroid-Induced Osteonecrosis of the Femoral Head Through Inhibiting Inflammatory Responses and Apoptosis via Network Pharmacology and Experimental Validation.通过网络药理学和实验验证抑制炎症反应和细胞凋亡预防类固醇诱导的股骨头坏死
Drug Des Devel Ther. 2025 Jul 9;19:5871-5898. doi: 10.2147/DDDT.S518115. eCollection 2025.
2
Qianggu concentrate: unlocking bone protection power via antioxidative SIRT1/NRF2/HO-1 pathways in type 2 diabetic osteoporosis.强骨浓缩物:通过抗氧化SIRT1/NRF2/HO-1途径解锁2型糖尿病骨质疏松症的骨骼保护能力
Front Pharmacol. 2024 Aug 8;15:1426767. doi: 10.3389/fphar.2024.1426767. eCollection 2024.
3

本文引用的文献

1
Anti-Osteoporotic Effects of Combined Extract of and in Osteoblast and Osteoclast Cells and Ovariectomized Mice.与联合提取物对成骨细胞和破骨细胞及去卵巢小鼠的抗骨质疏松作用。
Nutrients. 2019 Nov 9;11(11):2716. doi: 10.3390/nu11112716.
2
Effects of calcium supplementation on circulating osteocalcin and glycated haemoglobin in older women.补充钙对老年女性循环骨钙素和糖化血红蛋白的影响。
Osteoporos Int. 2019 Oct;30(10):2065-2072. doi: 10.1007/s00198-019-05087-3. Epub 2019 Jul 24.
3
Alkaline phosphatase is a predictor of Bone Mineral Density in postmenopausal females.
Plant-derived natural medicines for the management of osteoporosis: A comprehensive review of clinical trials.
用于骨质疏松症治疗的植物源天然药物:临床试验综述
J Tradit Complement Med. 2023 Aug 5;14(1):1-18. doi: 10.1016/j.jtcme.2023.08.001. eCollection 2024 Jan.
4
Anti-Osteoporotic Effect of Morroniside on Osteoblast and Osteoclast Differentiation In Vitro and Ovariectomized Mice In Vivo.Morroniside 对体外成骨细胞和破骨细胞分化及体内去卵巢小鼠的抗骨质疏松作用。
Int J Mol Sci. 2021 Sep 30;22(19):10642. doi: 10.3390/ijms221910642.
5
Active Components and Pharmacological Effects of : Literature Review.《[具体内容]的活性成分与药理作用:文献综述》 (这里因为原文冒号前不完整,所以译文补充完整的话需要加上具体是什么的综述,你可根据实际情况修改)
Front Pharmacol. 2021 Apr 12;12:633447. doi: 10.3389/fphar.2021.633447. eCollection 2021.
6
In Silico Network Analysis of Ingredients of Cornus officinalis in Osteoporosis.山茱萸治疗骨质疏松症的成分网络分析。
Med Sci Monit. 2021 Apr 2;27:e929219. doi: 10.12659/MSM.929219.
碱性磷酸酶是绝经后女性骨密度的一个预测指标。
Pak J Med Sci. 2019;35(3):749-753. doi: 10.12669/pjms.35.3.188.
4
Bone function, dysfunction and its role in diseases including critical illness.骨骼功能、功能障碍及其在包括危重病在内的疾病中的作用。
Int J Biol Sci. 2019 Jan 29;15(4):776-787. doi: 10.7150/ijbs.27063. eCollection 2019.
5
Denosumab-Induced Severe Hypocalcaemia in Chronic Kidney Disease.地诺单抗诱导的慢性肾脏病严重低钙血症
Case Rep Nephrol. 2018 Nov 4;2018:7384763. doi: 10.1155/2018/7384763. eCollection 2018.
6
Osteoporosis: A Review of Treatment Options.骨质疏松症:治疗方案综述
P T. 2018 Feb;43(2):92-104.
7
Osteoblast-osteoclast interactions.成骨细胞-破骨细胞相互作用。
Connect Tissue Res. 2018 Mar;59(2):99-107. doi: 10.1080/03008207.2017.1290085. Epub 2017 Mar 21.
8
The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA.新的国家骨骼健康联盟(NBHA)诊断标准对美国骨质疏松症患病率的影响。
Osteoporos Int. 2017 Apr;28(4):1225-1232. doi: 10.1007/s00198-016-3865-3. Epub 2016 Dec 13.
9
Osteoblast Differentiation at a Glance.成骨细胞分化一览
Med Sci Monit Basic Res. 2016 Sep 26;22:95-106. doi: 10.12659/msmbr.901142.
10
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - 2016--EXECUTIVE SUMMARY.美国临床内分泌医师协会和美国内分泌学会临床实践指南:绝经后骨质疏松症的诊断和治疗 - 2016 年——执行摘要。
Endocr Pract. 2016 Sep;22(9):1111-8. doi: 10.4158/EP161435.ESGL.